Full Breakdown
Rising Medicine Prices Amid the Iran Conflict
4/24/2026, 2:50:54 AM
Overview of the Situation
The ongoing war in Iran has significantly impacted global pharmaceutical prices, particularly in countries like the United Kingdom and India. The conflict has disrupted supply chains, leading to price increases for essential medications, including painkillers and allergy treatments. Pharmacists report that prices for over-the-counter medicines have surged by 20-30%, with some items, such as paracetamol, seeing increases of up to 96%.
Causes of Price Increases
The war has led to the blockade of the Strait of Hormuz, a critical shipping route for oil and liquefied natural gas, which has in turn affected the supply of petrochemical derivatives essential for drug manufacturing. Frederic Schneider, a senior fellow at the Middle East Council on Global Affairs, noted that pharmaceuticals are closely tied to petrochemical feedstocks sourced from the Persian Gulf. The disruption of logistics routes, particularly air transport, has compounded these issues, as approximately 35% of pharmaceuticals are transported by air, with 90% of critical medicines relying on this mode of transport.
Impact on Specific Medications
Pharmacies in the UK have reported that the price of paracetamol has increased from £1.19 to £1.50 for a 32-pack, while the cost of cetirizine has nearly doubled from 19p to 37p per pack. Olivier Picard, chair of the National Pharmacy Association, highlighted that suppliers are facing 40-50% higher costs for restocking, which they are passing on to consumers. In India, the price of paracetamol has risen dramatically, with reports indicating a potential further increase of 30-40%.
Affected Regions and Vulnerable Populations
The effects of the conflict are felt most acutely in countries directly impacted by the war, such as Lebanon and Palestine, as well as in fragile, aid-dependent nations like Sudan and Yemen. Schneider emphasized that these regions, which lack sufficient stockpiles and financial resources, are particularly vulnerable to the ongoing supply chain disruptions.
Official Responses and Future Outlook
While the UK government has assured that the majority of medicines remain in good supply, it is monitoring the situation closely. A spokesperson from the Department of Health and Social Care stated that measures are in place to manage potential disruptions. However, experts warn that if the conflict continues, the NHS and other health systems may face significant shortages and rising prices for essential medicines. Mark Samuels, chief executive of Medicines UK, indicated that transportation costs have surged by 700%, and without resolution, shortages could occur within weeks.
Criticism and Concerns
Pharmacists have expressed concerns about the sustainability of their operations amid rising costs. Picard noted that many pharmacies are dispensing medications at a loss due to fixed reimbursement rates from the NHS that do not account for the increased wholesale prices. The situation has already led to the closure of approximately 1,400 pharmacies since 2020, with closures continuing at a rate of one or two per week.
Verbatim Quotes
- “Pharmaceuticals are tied to both petrochemical feedstocks, a large part of which are sourced through the Persian Gulf,” — Frederic Schneider, Senior Fellow, Middle East Council on Global Affairs
- “If the conflict continues, we will inevitably see rising prices or shortages of essential medicines.” — Mark Samuels, Chief Executive, Medicines UK
The ongoing conflict in Iran continues to pose significant challenges to global pharmaceutical supply chains, with rising prices and potential shortages threatening access to essential medications for vulnerable populations worldwide.
